Application of kDNA Minicircle PCR-RFLP to Characterize <i>Leishmania donovani</i> Clinical Isolates Obtained from Post-Kala-Azar Dermal Leishmaniasis in Eastern Nepal

<div>Gel picture of <i>haspB</i> PCR showing PCR products at 320 bp and 640 bp. Note: M: DNA ladder, 1: BPK806/0, 2: BPK811/0, 3: BPK814/0, 4: BPK813/0, 5: 63232-Fx, 6: 63233-Fx, 7: 63238-Fx, 8: 63241-Fx, 9: 63245-Fx, 10: 63256-Fx, 11: 63269-Fx, 12: BPK-PKN435, 13: 63277-Fx, 14: BPK-PKN467, 15: BPK-PKN468, 16: negative control N1, and 17: negative control N2.</div>

Canadian Journal of Infectious Diseases and Medical Microbiology

fig2

Figure 2

Figure 2: Application of kDNA Minicircle PCR-RFLP to Characterize <i>Leishmania donovani</i> Clinical Isolates Obtained from Post-Kala-Azar Dermal Leishmaniasis in Eastern Nepal 

Figure 2 | Application of kDNA Minicircle PCR-RFLP to Characterize Leishmania donovani Clinical Isolates Obtained from Post-Kala-Azar Dermal Leishmaniasis in Eastern Nepal 